These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 23058884)
1. Discovery of novel pyrrolopyridazine scaffolds as transient receptor potential vanilloid (TRPV1) antagonists. Dorange I; Forsblom R; Macsari I; Svensson M; Bylund J; Besidski Y; Blid J; Sohn D; Gravenfors Y Bioorg Med Chem Lett; 2012 Nov; 22(22):6888-95. PubMed ID: 23058884 [TBL] [Abstract][Full Text] [Related]
2. Discovery of potent transient receptor potential vanilloid 1 antagonists: design and synthesis of phenoxyacetamide derivatives. Takahashi E; Hirano N; Nagahara T; Yoshikawa S; Momen S; Yokokawa H; Hayashi R Bioorg Med Chem Lett; 2013 Jun; 23(11):3154-6. PubMed ID: 23632270 [TBL] [Abstract][Full Text] [Related]
3. Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain. Culshaw AJ; Bevan S; Christiansen M; Copp P; Davis A; Davis C; Dyson A; Dziadulewicz EK; Edwards L; Eggelte H; Fox A; Gentry C; Groarke A; Hallett A; Hart TW; Hughes GA; Knights S; Kotsonis P; Lee W; Lyothier I; McBryde A; McIntyre P; Paloumbis G; Panesar M; Patel S; Seiler MP; Yaqoob M; Zimmermann K J Med Chem; 2006 Jan; 49(2):471-4. PubMed ID: 16420034 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists. Perner RJ; Koenig JR; Didomenico S; Gomtsyan A; Schmidt RG; Lee CH; Hsu MC; McDonald HA; Gauvin DM; Joshi S; Turner TM; Reilly RM; Kym PR; Kort ME Bioorg Med Chem; 2010 Jul; 18(13):4821-9. PubMed ID: 20570528 [TBL] [Abstract][Full Text] [Related]
5. Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Hodgetts KJ; Blum CA; Caldwell T; Bakthavatchalam R; Zheng X; Capitosti S; Krause JE; Cortright D; Crandall M; Murphy BA; Boyce S; Brian Jones A; Chenard BL Bioorg Med Chem Lett; 2010 Aug; 20(15):4359-63. PubMed ID: 20615696 [TBL] [Abstract][Full Text] [Related]
6. Discovery of pyrrolopyridazines as novel DGAT1 inhibitors. Fox BM; Iio K; Li K; Choi R; Inaba T; Jackson S; Sagawa S; Shan B; Tanaka M; Yoshida A; Kayser F Bioorg Med Chem Lett; 2010 Oct; 20(20):6030-3. PubMed ID: 20833038 [TBL] [Abstract][Full Text] [Related]
7. In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists. Perner RJ; DiDomenico S; Koenig JR; Gomtsyan A; Bayburt EK; Schmidt RG; Drizin I; Zheng GZ; Turner SC; Jinkerson T; Brown BS; Keddy RG; Lukin K; McDonald HA; Honore P; Mikusa J; Marsh KC; Wetter JM; George KS; Jarvis MF; Faltynek CR; Lee CH J Med Chem; 2007 Jul; 50(15):3651-60. PubMed ID: 17583335 [TBL] [Abstract][Full Text] [Related]
8. Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles. Ratcliffe P; Abernethy L; Ansari N; Cameron K; Clarkson T; Dempster M; Dunn D; Easson AM; Edwards D; Everett K; Feilden H; Ho KK; Kultgen S; Littlewood P; Maclean J; McArthur D; McGregor D; McLuskey H; Neagu I; Nimz O; Nisbet LA; Ohlmeyer M; Palin R; Pham Q; Rong Y; Roughton A; Sammons M; Swanson R; Tracey H; Walker G Bioorg Med Chem Lett; 2011 Aug; 21(15):4652-7. PubMed ID: 21723725 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of phenylpropanamides as novel transient receptor potential vanilloid 1 antagonists. Li FN; Kim NJ; Nam YH; Kim SH; Seo SY; Jeong YS; Kim SY; Park YH; Suh YG Arch Pharm Res; 2009 Sep; 32(9):1201-10. PubMed ID: 19784574 [TBL] [Abstract][Full Text] [Related]
11. Triazine-based vanilloid 1 receptor open channel blockers: design, synthesis, evaluation, and SAR analysis. Vidal-Mosquera M; Fernández-Carvajal A; Moure A; Valente P; Planells-Cases R; González-Ros JM; Bujons J; Ferrer-Montiel A; Messeguer A J Med Chem; 2011 Nov; 54(21):7441-52. PubMed ID: 21950613 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of indole-based peptoids as potent noncompetitive antagonists of transient receptor potential vanilloid 1. Quintanar-Audelo M; Fernández-Carvajal A; Van Den Nest W; Carreño C; Ferrer-Montiel A; Albericio F J Med Chem; 2007 Nov; 50(24):6133-43. PubMed ID: 17985859 [TBL] [Abstract][Full Text] [Related]
15. Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility. Wang X; Chakrabarti PP; Ognyanov VI; Pettus LH; Tamir R; Tan H; Tang P; Treanor JJ; Gavva NR; Norman MH Bioorg Med Chem Lett; 2007 Dec; 17(23):6539-45. PubMed ID: 17937985 [TBL] [Abstract][Full Text] [Related]
16. Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists. Hawryluk NA; Merit JE; Lebsack AD; Branstetter BJ; Hack MD; Swanson N; Ao H; Maher MP; Bhattacharya A; Wang Q; Freedman JM; Scott BP; Wickenden AD; Chaplan SR; Breitenbucher JG Bioorg Med Chem Lett; 2010 Dec; 20(23):7137-41. PubMed ID: 20947352 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists. Li FN; Kim NJ; Paek SM; Kwon DY; Min KH; Jeong YS; Kim SY; Park YH; Kim HD; Park HG; Suh YG Bioorg Med Chem; 2009 May; 17(10):3557-67. PubMed ID: 19398205 [TBL] [Abstract][Full Text] [Related]
18. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord. Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316 [TBL] [Abstract][Full Text] [Related]